| Product NDC: | 16590-883 |
| Proprietary Name: | BRIMONIDINE TARTRATE |
| Non Proprietary Name: | BRIMONIDINE TARTRATE |
| Active Ingredient(s): | 2 mg/mL & nbsp; BRIMONIDINE TARTRATE |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-883 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076260 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030528 |
| Package NDC: | 16590-883-10 |
| Package Description: | 10 mL in 1 BOTTLE, DROPPER (16590-883-10) |
| NDC Code | 16590-883-10 |
| Proprietary Name | BRIMONIDINE TARTRATE |
| Package Description | 10 mL in 1 BOTTLE, DROPPER (16590-883-10) |
| Product NDC | 16590-883 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BRIMONIDINE TARTRATE |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20030528 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | BRIMONIDINE TARTRATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |